297 related articles for article (PubMed ID: 20096366)
1. Genetics and molecular pathology of Stargardt-like macular degeneration.
Vasireddy V; Wong P; Ayyagari R
Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
[TBL] [Abstract][Full Text] [Related]
2. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
3. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
[TBL] [Abstract][Full Text] [Related]
4. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
Vasireddy V; Jablonski MM; Khan NW; Wang XF; Sahu P; Sparrow JR; Ayyagari R
Exp Eye Res; 2009 Dec; 89(6):905-12. PubMed ID: 19682985
[TBL] [Abstract][Full Text] [Related]
5. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
McMahon A; Butovich IA; Kedzierski W
J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
[TBL] [Abstract][Full Text] [Related]
6. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
7. Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.
Okuda A; Naganuma T; Ohno Y; Abe K; Yamagata M; Igarashi Y; Kihara A
Mol Vis; 2010 Nov; 16():2438-45. PubMed ID: 21139992
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
[TBL] [Abstract][Full Text] [Related]
9. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
[TBL] [Abstract][Full Text] [Related]
11. Defective phagosome motility and degradation in cell nonautonomous RPE pathogenesis of a dominant macular degeneration.
Esteve-Rudd J; Hazim RA; Diemer T; Paniagua AE; Volland S; Umapathy A; Williams DS
Proc Natl Acad Sci U S A; 2018 May; 115(21):5468-5473. PubMed ID: 29735674
[TBL] [Abstract][Full Text] [Related]
12. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.
Li W; Chen Y; Cameron DJ; Wang C; Karan G; Yang Z; Zhao Y; Pearson E; Chen H; Deng C; Howes K; Zhang K
Vision Res; 2007 Mar; 47(5):714-22. PubMed ID: 17254625
[TBL] [Abstract][Full Text] [Related]
13. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
14. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
15. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family.
Edwards AO; Donoso LA; Ritter R
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2652-63. PubMed ID: 11581213
[TBL] [Abstract][Full Text] [Related]
16. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.
Zhang K; Kniazeva M; Han M; Li W; Yu Z; Yang Z; Li Y; Metzker ML; Allikmets R; Zack DJ; Kakuk LE; Lagali PS; Wong PW; MacDonald IM; Sieving PA; Figueroa DJ; Austin CP; Gould RJ; Ayyagari R; Petrukhin K
Nat Genet; 2001 Jan; 27(1):89-93. PubMed ID: 11138005
[TBL] [Abstract][Full Text] [Related]
17. DHA does not protect ELOVL4 transgenic mice from retinal degeneration.
Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE
Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303
[TBL] [Abstract][Full Text] [Related]
18. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
[TBL] [Abstract][Full Text] [Related]
19. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration.
Vasireddy V; Jablonski MM; Mandal MN; Raz-Prag D; Wang XF; Nizol L; Iannaccone A; Musch DC; Bush RA; Salem N; Sieving PA; Ayyagari R
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4558-68. PubMed ID: 17003453
[TBL] [Abstract][Full Text] [Related]
20. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
